Efficacy and Safety of Iptacopan in Patients with C3 Glomerulopathy: 12-Month Results from the Phase 3 APPEAR-C3G Study

Authors: Nester, Carla M., Smith, Richard J., Kavanagh, David, Vivarelli, Marina, Remuzzi, Giuseppe, Zhao, Ming-Hui, Wong, Edwin Kwan Soon, Wang, Yaqin, Trapani, Angelo J., Krishnan, Induja, Webb, Nicholas J., Meier, Matthias, Bomback, Andrew S.

Source: Journal of the American Society of Nephrology; October 2024, Vol. 35 Issue: 10, Number 10 Supplement 10

Stopping Eculizumab Treatment Safely in Atypical Haemolytic Uraemic Syndrome (SETS aHUS): A Multicentre, Open-Label, Prospective, Single-Arm Trial of the Safety and Impact of Eculizumab Withdrawal

Authors: Sheerin, Neil S., Johnson, Sally A., Wong, Edwin Kwan Soon, Vale, Luke, Malina, Michal, Orozco Leal, Giovany, Kennedy, Ciara Anne-Marie, Dunn, Sarah, Kavanagh, David

Source: Journal of the American Society of Nephrology; October 2024, Vol. 35 Issue: 10, Number 10 Supplement 10